Ramsay Health Care Ltd (RHC.AU) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Ramsay Health Care Ltd ranks 7 of 8 in its cohort on the Closelook composite (45/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
RHC.AU Ramsay Health Care Ltd 45 91 22 53 ok 1.1%
PACS PACS Group, Inc. 54 73 39 54 info 14.9%
ANN.AU Ansell Ltd 63 91 46 54 ok 0.8%
TLX.AU TELIX Pharmaceuticals Ltd 39 89 27 17 ok 2.6%
BION.SW BB Biotech AG 74 74 96 81 info 8.2%
DXCM DexCom Inc 66 86 80 35 bull 5%
ARGX.BR Argen-X 65 79 75 28 ok 5.8%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Ramsay Health Care Ltd's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: PACS Group, Inc. (PACS), Ansell Ltd (ANN.AU), TELIX Pharmaceuticals Ltd (TLX.AU), BB Biotech AG (BION.SW), DexCom Inc (DXCM), Argen-X (ARGX.BR), argenx NV ADR (ARGX).

How does RHC.AU score against its peers?

Ramsay Health Care Ltd's composite reads 45/100, ranking 7 of 8 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.